A training network for the development of novel anti-infective drugs
The discovery of specific anti-microbial compounds with a novel mode of action is necessary to tackle the emergence of drug resistance. The EU-funded MepAnti project is an interdisciplinary effort that aims to train the next generation of scientists in the discovery and optimisation of new drugs. It will offer training and cutting-edge research skills in structural biology, the design and synthesis of inhibitors as well as lead molecule-testing methodologies. The key objective is to address medically relevant pathogens such as the causative agents of malaria and tuberculosis through the development of selective inhibitors.
Fields of science
Call for proposal
See other projects for this call
Funding SchemeMSCA-ITN-ETN - European Training Networks
2712 PB Zoetermeer